Geode Capital Management, LLC Biogen Inc. Transaction History

Geode Capital Management, LLC

  • $1.24 Trillion
  • Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,846,864 shares of BIIB stock, worth $504 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,846,864
Previous 3,695,476 4.1%
Holding current value
$504 Million
Previous $565 Million 6.85%
% of portfolio
0.04%
Previous 0.04%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$133.43 - $153.27 $20.2 Million - $23.2 Million
151,388 Added 4.1%
3,846,864 $526 Million
Q4 2024

Feb 12, 2025
BUY
$146.47 - $191.55 $12.1 Million - $15.8 Million
82,456 Added 2.28%
3,695,476 $565 Million
Q3 2024

Nov 12, 2024
BUY
$189.07 - $236.8 $8.9 Million - $11.1 Million
47,055 Added 1.32%
3,613,020 $700 Million
Q2 2024

Aug 09, 2024
BUY
$190.52 - $236.72 $29.8 Million - $37 Million
156,291 Added 4.58%
3,565,965 $827 Million
Q1 2024

May 13, 2024
BUY
$212.02 - $267.71 $21.3 Million - $26.9 Million
100,357 Added 3.03%
3,409,674 $735 Million
Q4 2023

Feb 13, 2024
BUY
$222.59 - $267.94 $16.1 Million - $19.4 Million
72,430 Added 2.24%
3,309,317 $856 Million
Q3 2023

Nov 13, 2023
BUY
$253.3 - $285.89 $13.5 Million - $15.2 Million
53,208 Added 1.67%
3,236,887 $832 Million
Q2 2023

Aug 11, 2023
BUY
$275.25 - $318.06 $22.3 Million - $25.7 Million
80,944 Added 2.61%
3,183,679 $907 Million
Q1 2023

May 15, 2023
SELL
$256.56 - $292.34 $61.5 Million - $70 Million
-239,595 Reduced 7.17%
3,102,735 $863 Million
Q4 2022

Feb 13, 2023
BUY
$252.44 - $306.72 $10.8 Million - $13.1 Million
42,855 Added 1.3%
3,342,330 $924 Million
Q3 2022

Nov 14, 2022
BUY
$194.69 - $268.46 $10.5 Million - $14.5 Million
53,952 Added 1.66%
3,299,475 $880 Million
Q2 2022

Aug 12, 2022
BUY
$187.54 - $223.02 $82.3 Million - $97.9 Million
438,859 Added 15.64%
3,245,523 $661 Million
Q1 2022

May 13, 2022
BUY
$193.77 - $244.14 $11.9 Million - $15 Million
61,333 Added 2.23%
2,806,664 $590 Million
Q4 2021

Feb 11, 2022
SELL
$223.92 - $287.77 $6.7 Million - $8.61 Million
-29,935 Reduced 1.08%
2,745,331 $657 Million
Q3 2021

Nov 12, 2021
SELL
$282.99 - $369.05 $33.5 Million - $43.7 Million
-118,484 Reduced 4.09%
2,775,266 $783 Million
Q2 2021

Aug 13, 2021
BUY
$259.0 - $414.71 $25.2 Million - $40.3 Million
97,239 Added 3.48%
2,893,750 $1 Billion
Q1 2021

May 12, 2021
BUY
$242.95 - $284.63 $8.99 Million - $10.5 Million
37,013 Added 1.34%
2,796,511 $781 Million
Q4 2020

Feb 12, 2021
SELL
$236.26 - $355.63 $30.8 Million - $46.4 Million
-130,480 Reduced 4.51%
2,759,498 $674 Million
Q3 2020

Nov 13, 2020
SELL
$264.77 - $305.71 $39.6 Million - $45.7 Million
-149,428 Reduced 4.92%
2,889,978 $819 Million
Q2 2020

Aug 13, 2020
SELL
$258.66 - $342.55 $86.1 Million - $114 Million
-332,888 Reduced 9.87%
3,039,406 $812 Million
Q1 2020

May 14, 2020
BUY
$268.85 - $341.04 $18.7 Million - $23.8 Million
69,657 Added 2.11%
3,372,294 $1.07 Billion
Q4 2019

Feb 13, 2020
SELL
$220.06 - $304.07 $7.24 Million - $10 Million
-32,915 Reduced 0.99%
3,302,637 $978 Million
Q3 2019

Nov 12, 2019
BUY
$217.44 - $243.88 $10.6 Million - $11.9 Million
48,970 Added 1.49%
3,335,552 $776 Million
Q2 2019

Aug 14, 2019
BUY
$219.29 - $241.72 $53.4 Million - $58.8 Million
243,391 Added 8.0%
3,286,582 $768 Million
Q1 2019

May 14, 2019
BUY
$216.71 - $338.96 $71.4 Million - $112 Million
329,614 Added 12.15%
3,043,191 $718 Million
Q4 2018

Feb 13, 2019
BUY
$278.5 - $352.75 $40.2 Million - $51 Million
144,464 Added 5.62%
2,713,577 $815 Million
Q3 2018

Nov 13, 2018
SELL
$293.51 - $383.83 $15.8 Million - $20.6 Million
-53,707 Reduced 2.05%
2,569,113 $906 Million
Q2 2018

Aug 14, 2018
BUY
$257.52 - $306.91 $7.32 Million - $8.72 Million
28,421 Added 1.1%
2,622,820 $760 Million
Q1 2018

May 15, 2018
BUY
$260.13 - $367.91 $39.2 Million - $55.5 Million
150,840 Added 6.17%
2,594,399 $709 Million
Q4 2017

Feb 13, 2018
BUY
$307.64 - $344.58 $7.62 Million - $8.53 Million
24,753 Added 1.02%
2,443,559 $777 Million
Q3 2017

Nov 14, 2017
SELL
$281.15 - $329.69 $202,427 - $237,376
-720 Reduced 0.03%
2,418,806 $756 Million
Q2 2017

Aug 14, 2017
BUY
N/A
2,419,526
2,419,526 $656 Million

Others Institutions Holding BIIB

# of Institutions
1,026
Shares Held
127M
Call Options Held
2.29M
Put Options Held
4.26M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $18.9B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email